Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China · Delayed Price · Currency is CNY 18.53
+0.60 (3.35%)
At close: Sep 30, 2026
SHE:301584 Revenue
Shanghai C&D INNOSTIC Medical Technology Group had revenue of 4.52B CNY in the quarter ending March 31, 2026, with 1.96% growth. This brings the company's revenue in the last twelve months to 19.44B, up 7.64% year-over-year. In the year 2025, Shanghai C&D INNOSTIC Medical Technology Group had annual revenue of 19.43B with 8.41% growth.
Revenue (ttm)
19.44B
Revenue Growth
+7.64%
P/S Ratio
0.40
Revenue / Employee
9.19M
Employees
2,115
Market Cap
7.81B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.43B | 1.51B | 8.41% |
| Dec 31, 2024 | 17.92B | 2.48B | 16.06% |
| Dec 31, 2023 | 15.44B | 3.56B | 29.97% |
| Dec 31, 2022 | 11.88B | 1.86B | 18.54% |
| Dec 31, 2021 | 10.02B | 1.48B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Windey Energy Technology Group | 32.33B |
| Gold cup Electric Apparatus | 22.85B |
| Shenzhen Cereals Holdings | 5.51B |
| Zhejiang Tianyu Pharmaceutical | 3.30B |
| Kingsignal Technology | 2.76B |
| Zhejiang ZUCH Technology | 2.08B |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.88B |
| Guangdong Southern New Media | 1.56B |